NCT06178744 A Study of AI in Cardiac Transplant in Echocardiographic Analysis (ORACLE)
| NCT ID | NCT06178744 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Cardiac Transplant Rejection |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2024-04-04 |
| Primary Completion | 2027-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2024-04-04 with a primary completion date of 2027-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this research is to detect episodes of rejection versus non-rejection after cardiac transplant and the diagnostic accuracy of an Artificial Intelligence (AI) algorithm using the data from an ECG (electrocardiogram) and Cardiac Ultrasound (Echocardiogram and/or point of care ultrasound).
Eligibility Criteria
Inclusion Criteria: * Patients undergoing post-cardiac transplant endomyocardial biopsy, and the ability to provide informed consent and a consent for the study. Exclusion Criteria: * Refusal of study participation
Contact & Investigator
Atta Behfar, MD, PhD
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT06178744 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiac Transplant Rejection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06178744 currently recruiting?
Yes, NCT06178744 is actively recruiting participants. Contact the research team at lokensgard.alyssa@mayo.edu for enrollment information.
Where is the NCT06178744 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT06178744 clinical trial?
NCT06178744 is sponsored by Mayo Clinic. The principal investigator is Atta Behfar, MD, PhD at Mayo Clinic. The trial plans to enroll 500 participants.